메뉴 건너뛰기




Volumn 7, Issue 2, 2015, Pages 85-89

The promise of reverse vaccinology

Author keywords

Bacterial pathogen; Epidemic; Reverse vaccinology; Subunit vaccine

Indexed keywords

ANTIGEN; EPITOPE; MENINGOCOCCUS VACCINE; PROTEOME; SUBUNIT VACCINE; 4CMENB VACCINE; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; VACCINE;

EID: 84924509926     PISSN: 18763413     EISSN: 18763405     Source Type: Journal    
DOI: 10.1093/inthealth/ihv002     Document Type: Article
Times cited : (53)

References (40)
  • 2
    • 77958454595 scopus 로고    scopus 로고
    • Reverse vaccinology: developing vaccines in the era of genomics
    • Sette A, Rappuoli R. Reverse vaccinology: developing vaccines in the era of genomics. Immunity 2010;33:530-41.
    • (2010) Immunity , vol.33 , pp. 530-541
    • Sette, A.1    Rappuoli, R.2
  • 4
    • 84899493964 scopus 로고    scopus 로고
    • Identification of potential vaccine candidates against Streptococcus pneumoniae by reverse vaccinology approach
    • Talukdar S, Zutshi S, Prashanth KS et al. Identification of potential vaccine candidates against Streptococcus pneumoniae by reverse vaccinology approach. Appl Biochem Biotechnol 2014;172:3026-41.
    • (2014) Appl Biochem Biotechnol , vol.172 , pp. 3026-3041
    • Talukdar, S.1    Zutshi, S.2    Prashanth, K.S.3
  • 5
    • 80053647416 scopus 로고    scopus 로고
    • Improving reverse vaccinology with a machine learning approach
    • Bowman BN, McAdam PR, Vivona S et al. Improving reverse vaccinology with a machine learning approach. Vaccine 2011;29:8156-64.
    • (2011) Vaccine , vol.29 , pp. 8156-8164
    • Bowman, B.N.1    McAdam, P.R.2    Vivona, S.3
  • 6
    • 84879494011 scopus 로고    scopus 로고
    • Jenner-predict server:prediction of protein vaccine candidates (PVCs) in bacteria based on host-pathogen interactions
    • Jaiswal V, Chanumolu SK, Gupta A et al. Jenner-predict server:prediction of protein vaccine candidates (PVCs) in bacteria based on host-pathogen interactions. BMC Bioinformatics 2013;14:211.
    • (2013) BMC Bioinformatics , vol.14 , pp. 211
    • Jaiswal, V.1    Chanumolu, S.K.2    Gupta, A.3
  • 8
    • 84900385250 scopus 로고    scopus 로고
    • Use of a multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) for bacterial meningitis prevention
    • Esposito S, Castellazzi L, Bosco A et al. Use of a multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) for bacterial meningitis prevention. Immunotherapy 2014;6:395-408.
    • (2014) Immunotherapy , vol.6 , pp. 395-408
    • Esposito, S.1    Castellazzi, L.2    Bosco, A.3
  • 9
    • 77955360252 scopus 로고    scopus 로고
    • Vaxign: the first web-based vaccine design program for reverse vaccinology and applications for vaccine development
    • 2010
    • He Y, Xiang Z, Mobley HL. Vaxign: the first web-based vaccine design program for reverse vaccinology and applications for vaccine development. J Biomed Biotechnol 2010;2010:297505.
    • (2010) J Biomed Biotechnol , pp. 297505
    • He, Y.1    Xiang, Z.2    Mobley, H.L.3
  • 10
    • 84924466660 scopus 로고    scopus 로고
    • Atlanta: U.S. Department of Health and Human Services, Centers for Disease, Control and Prevention;
    • U.S. Department of Health and Human Services CfD, Control and Prevention. Antibiotic resistance threats in the United States, 2013. Atlanta: U.S. Department of Health and Human Services, Centers for Disease, Control and Prevention; 2013.
    • (2013)
  • 11
    • 33750223990 scopus 로고    scopus 로고
    • Antibiotic resistance--action to promote new technologies: report of an EU Intergovernmental Conference held in Birmingham
    • UK, 12-13 December 2005
    • Finch R, Hunter PA. Antibiotic resistance--action to promote new technologies: report of an EU Intergovernmental Conference held in Birmingham, UK, 12-13 December 2005. J Antimicrob Chemother 2006;58(Suppl 1):i3-22.
    • (2006) J Antimicrob Chemother , vol.58 , pp. i3-22
    • Finch, R.1    Hunter, P.A.2
  • 12
  • 13
    • 33746456834 scopus 로고    scopus 로고
    • CED: a conformational epitope database
    • Huang J, Honda W. CED: a conformational epitope database. BMC Immunol 2006;7:7.
    • (2006) BMC Immunol , vol.7 , pp. 7
    • Huang, J.1    Honda, W.2
  • 14
    • 77958498224 scopus 로고    scopus 로고
    • Vaccine adjuvants: putting innate immunity to work
    • Coffman RL, Sher A, Seder RA. Vaccine adjuvants: putting innate immunity to work. Immunity 2010;33:492-503.
    • (2010) Immunity , vol.33 , pp. 492-503
    • Coffman, R.L.1    Sher, A.2    Seder, R.A.3
  • 15
    • 77955421572 scopus 로고    scopus 로고
    • Hepatitis B vaccines: protective efficacy and therapeutic potential
    • Michel ML, Tiollais P. Hepatitis B vaccines: protective efficacy and therapeutic potential. Pathol Biol (Paris) 2010;58:288-95.
    • (2010) Pathol Biol (Paris) , vol.58 , pp. 288-295
    • Michel, M.L.1    Tiollais, P.2
  • 16
    • 23244467904 scopus 로고    scopus 로고
    • Boostrix (GlaxoSmithKline)
    • Jones T. Boostrix (GlaxoSmithKline). IDrugs 2005;8:656-61.
    • (2005) IDrugs , vol.8 , pp. 656-661
    • Jones, T.1
  • 17
    • 84873378947 scopus 로고    scopus 로고
    • Reduced-antigen, combined diphtheria, tetanus, and acellular pertussis vaccine, adsorbed (boostrix (R)): a guide to its use as a single-dose booster immunization against pertussis
    • Scott LJ, McCormack PL. Reduced-antigen, combined diphtheria, tetanus, and acellular pertussis vaccine, adsorbed (boostrix (R)): a guide to its use as a single-dose booster immunization against pertussis. BioDrugs 2013;27:75-81.
    • (2013) BioDrugs , vol.27 , pp. 75-81
    • Scott, L.J.1    McCormack, P.L.2
  • 18
    • 84924466659 scopus 로고    scopus 로고
    • Novartis Bexsero® meningitis B vaccine receives clinical recommendation for use in infants and adolescents in Australia
    • 17 March, accessed 10 September 2014
    • Friend R, Staton T. Novartis Bexsero® meningitis B vaccine receives clinical recommendation for use in infants and adolescents in Australia. FierceVaccines, 17 March 2014. http://www.fiercepharma. com/press-releases/novartis-bexsero-meningitis-b-vaccine-receivesclinical- recommendation-use [accessed 10 September 2014].
    • (2014) FierceVaccines
    • Friend, R.1    Staton, T.2
  • 19
    • 0034629284 scopus 로고    scopus 로고
    • Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing
    • Pizza M, Scarlato V, Masignani V et al. Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 2000;287:1816-20.
    • (2000) Science , vol.287 , pp. 1816-1820
    • Pizza, M.1    Scarlato, V.2    Masignani, V.3
  • 21
    • 79958035895 scopus 로고    scopus 로고
    • Recombinant protein meningococcal serogroup B vaccine combined with outer membrane vesicles
    • Bai X, Findlow J, Borrow R. Recombinant protein meningococcal serogroup B vaccine combined with outer membrane vesicles. Expert Opin Biol Ther 2011;11:969-85.
    • (2011) Expert Opin Biol Ther , vol.11 , pp. 969-985
    • Bai, X.1    Findlow, J.2    Borrow, R.3
  • 22
    • 84893929367 scopus 로고    scopus 로고
    • Quantification by LC-MS(E) of outer membrane vesicle proteins of the Bexsero(R) vaccine
    • Tani C, Stella M, Donnarumma D et al. Quantification by LC-MS(E) of outer membrane vesicle proteins of the Bexsero(R) vaccine. Vaccine 2014;32:1273-9.
    • (2014) Vaccine , vol.32 , pp. 1273-1279
    • Tani, C.1    Stella, M.2    Donnarumma, D.3
  • 23
    • 84924466658 scopus 로고    scopus 로고
    • Meningitis B Vaccine, accessed 10 May 2014
    • NHS. Meningitis B Vaccine. http://www.nhs.uk/Conditions/vaccinations/ Pages/meningitis-B-vaccine.aspx [accessed 10 May 2014].
  • 24
    • 84898007270 scopus 로고    scopus 로고
    • vaccine to be introduced in UK after U turn on its cost effectiveness
    • Wise J. Meningitis B vaccine to be introduced in UK after U turn on its cost effectiveness. BMJ 2014;348:2327.
    • (2014) BMJ , vol.348 , pp. 2327
    • Wise, J.1    Meningitis, B.2
  • 25
    • 19944423389 scopus 로고    scopus 로고
    • Identification of new potential vaccine candidates against Chlamydia pneumoniae by multiple screenings
    • Finco O, Bonci A, Agnusdei M et al. Identification of new potential vaccine candidates against Chlamydia pneumoniae by multiple screenings. Vaccine 2005;23:1178-88.
    • (2005) Vaccine , vol.23 , pp. 1178-1188
    • Finco, O.1    Bonci, A.2    Agnusdei, M.3
  • 26
    • 14844324488 scopus 로고    scopus 로고
    • Whole-genome analysis of Leptospira interrogans to identify potential vaccine candidates against leptospirosis
    • Gamberini M, Gomez RM, AtzingenMVet al. Whole-genome analysis of Leptospira interrogans to identify potential vaccine candidates against leptospirosis. FEMS Microbiol Lett 2005;244:305-13.
    • (2005) FEMS Microbiol Lett , vol.244 , pp. 305-313
    • Gamberini, M.1    Gomez, R.M.2    Atzingen, M.V.3
  • 27
    • 0036893688 scopus 로고    scopus 로고
    • Search for potential vaccine candidate open reading frames in the Bacillus anthracis virulence plasmid pXO1: in silico and in vitro screening
    • Ariel N, Zvi A, Grosfeld H et al. Search for potential vaccine candidate open reading frames in the Bacillus anthracis virulence plasmid pXO1: in silico and in vitro screening. Infect Immun 2002;70:6817-27.
    • (2002) Infect Immun , vol.70 , pp. 6817-6827
    • Ariel, N.1    Zvi, A.2    Grosfeld, H.3
  • 28
    • 33745617720 scopus 로고    scopus 로고
    • Search for Bacillus anthracis potential vaccine candidates by a functional genomic-serologic screen
    • Gat O, Grosfeld H, Ariel N et al. Search for Bacillus anthracis potential vaccine candidates by a functional genomic-serologic screen. Infect Immun 2006;74:3987-4001.
    • (2006) Infect Immun , vol.74 , pp. 3987-4001
    • Gat, O.1    Grosfeld, H.2    Ariel, N.3
  • 29
    • 0035114563 scopus 로고    scopus 로고
    • Use of a whole genome approach to identify vaccine molecules affording protection against Streptococcus pneumoniae infection
    • Wizemann TM, Heinrichs JH, Adamou JE et al. Use of a whole genome approach to identify vaccine molecules affording protection against Streptococcus pneumoniae infection. Infect Immun 2001;69:1593-8.
    • (2001) Infect Immun , vol.69 , pp. 1593-1598
    • Wizemann, T.M.1    Heinrichs, J.H.2    Adamou, J.E.3
  • 30
    • 1642498273 scopus 로고    scopus 로고
    • Identification of new candidate vaccine antigens made by Streptococcus pyogenes: purification and characterization of 16 putative extracellular lipoproteins
    • Lei B, Liu M, Chesney GL, Musser JM. Identification of new candidate vaccine antigens made by Streptococcus pyogenes: purification and characterization of 16 putative extracellular lipoproteins. J Infect Dis 2004;189:79-89.
    • (2004) J Infect Dis , vol.189 , pp. 79-89
    • Lei, B.1    Liu, M.2    Chesney, G.L.3    Musser, J.M.4
  • 31
    • 7044274377 scopus 로고    scopus 로고
    • Utility of the Trypanosoma cruzi sequence database for identification of potential vaccine candidates by in silico and in vitro screening
    • Bhatia V, Sinha M, Luxon B, Garg N. Utility of the Trypanosoma cruzi sequence database for identification of potential vaccine candidates by in silico and in vitro screening. Infect Immun 2004;72:6245-54.
    • (2004) Infect Immun , vol.72 , pp. 6245-6254
    • Bhatia, V.1    Sinha, M.2    Luxon, B.3    Garg, N.4
  • 32
    • 33847031827 scopus 로고    scopus 로고
    • VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines
    • Doytchinova IA, Flower DR. VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinformatics 2007;8:4.
    • (2007) BMC Bioinformatics , vol.8 , pp. 4
    • Doytchinova, I.A.1    Flower, D.R.2
  • 33
    • 84904732727 scopus 로고    scopus 로고
    • Vacceed: a high-throughput in silico vaccine candidate discovery pipeline for eukaryotic pathogens based on reverse vaccinology
    • Goodswen SJ, Kennedy PJ, Ellis JT. Vacceed: a high-throughput in silico vaccine candidate discovery pipeline for eukaryotic pathogens based on reverse vaccinology. Bioinformatics 2014;30:2381-3.
    • (2014) Bioinformatics , vol.30 , pp. 2381-2383
    • Goodswen, S.J.1    Kennedy, P.J.2    Ellis, J.T.3
  • 34
    • 84886737285 scopus 로고    scopus 로고
    • A novel strategy for classifying the output from an in silico vaccine discovery pipeline for eukaryotic pathogens using machine learning algorithms
    • Goodswen SJ, Kennedy PJ, Ellis JT. A novel strategy for classifying the output from an in silico vaccine discovery pipeline for eukaryotic pathogens using machine learning algorithms. BMC Bioinformatics 2013;14:315.
    • (2013) BMC Bioinformatics , vol.14 , pp. 315
    • Goodswen, S.J.1    Kennedy, P.J.2    Ellis, J.T.3
  • 35
    • 33747839161 scopus 로고    scopus 로고
    • SVMHC: a server for prediction of MHC-binding peptides
    • Web Server issue
    • Donnes P, Kohlbacher O. SVMHC: a server for prediction of MHC-binding peptides. Nucleic Acids Res 2006;34(Web Server issue):W194-7.
    • (2006) Nucleic Acids Res , vol.34 , pp. W194-W197
    • Donnes, P.1    Kohlbacher, O.2
  • 37
    • 80055113866 scopus 로고    scopus 로고
    • Legionella: Drinking water fact sheet
    • Washington DC: United States Environmental Protection Agency Office of Wate;
    • United States Environmental Protection Agency. Legionella: Drinking water fact sheet. Washington DC: United States Environmental Protection Agency Office of Wate; 2000.
    • (2000)
  • 38
    • 84867609003 scopus 로고    scopus 로고
    • Activity of macrolides and fluoroquinolones against intracellular Legionella pneumophila [in Chinese]
    • Yu LL, Hu BJ, Huang SL et al. Activity of macrolides and fluoroquinolones against intracellular Legionella pneumophila [in Chinese]. Zhonghua Jie He He Hu Xi Za Zhi 2011;34:409-12.
    • (2011) Zhonghua Jie He He Hu Xi Za Zhi , vol.34 , pp. 409-412
    • Yu, L.L.1    Hu, B.J.2    Huang, S.L.3
  • 39
    • 84897934240 scopus 로고    scopus 로고
    • Bacterial outer membrane vesicles and vaccine applications
    • Acevedo R, Fernandez S, Zayas C et al. Bacterial outer membrane vesicles and vaccine applications. Front Immunol 2014;5:121.
    • (2014) Front Immunol , vol.5 , pp. 121
    • Acevedo, R.1    Fernandez, S.2    Zayas, C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.